| First Author | Dupont LL | Year | 2014 |
| Journal | Pulm Pharmacol Ther | Volume | 28 |
| Issue | 1 | Pages | 60-7 |
| PubMed ID | 24183679 | Mgi Jnum | J:261502 |
| Mgi Id | MGI:6156520 | Doi | 10.1016/j.pupt.2013.10.003 |
| Citation | Dupont LL, et al. (2014) Investigation of 5-HT4 receptors in bronchial hyperresponsiveness in cigarette smoke-exposed mice. Pulm Pharmacol Ther 28(1):60-7 |
| abstractText | BACKGROUND: Chronic obstructive pulmonary disease (COPD) arises from an interaction between genetic host factors and environmental exposures (mainly cigarette smoke (CS)). Genome Wide Association studies have demonstrated that genetic variations in the gene encoding 5-hydroxytryptamine 4 receptors (5-HT(4)R), HTR4, were associated with measures of airway obstruction and with COPD. We hypothesised that 5-HT(4) receptors, in addition to 5-HT2AR and muscarinic receptors, contribute to the pathogenesis of COPD by facilitating cholinergic bronchoconstriction. METHODS: The levels of pulmonary 5-HT(4)R mRNA were measured in CS-exposed mice by qRT-PCR. We investigated the effect of CS exposure on bronchial hyperresponsiveness (BHR) to 5-HT and evaluated the contribution of 5-HT2AR, muscarinic receptors and 5-HT(4)R in the response to 5-HT by using the corresponding antagonists and 5-HT(4)R knockout (KO) mice. RESULTS: The 5-HT(4)R mRNA levels were significantly elevated upon acute (3 days), subacute (4 weeks) and chronic (24 weeks) CS exposure. Both acute and subacute CS exposure significantly increased BHR to 5-HT. Antagonism of 5-HT2AR abolished the CS-induced BHR to 5-HT, and antagonism of muscarinic receptors significantly reduced the response to 5-HT. However, pre-treatment with GR113808, a specific 5-HT(4)R antagonist, did not alter the response to 5-HT in CS-exposed mice. Accordingly, the CS-induced BHR to 5-HT was not different between wild-type and 5-HT(4)R KO mice. CONCLUSION: CS increased the levels of 5-HT(4)R mRNA in the lungs, concomitantly with bronchial responsiveness to 5-HT. Our in vivo data using pharmacologic and genetic approaches suggest that 5-HT(4) receptors are not involved in the BHR to 5-HT in CS-exposed mice. |
